Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Lexagene has a large competitive advantage & will be bought

<< Previous

Bullboard Posts

Next >>

Comment by ARIMA11on Dec 16, 2021 5:36pm

325 Views

Post# 34238685

RE:Lexagene has a large competitive advantage & will be bought

Notmypres wrote: I like the technology and trust the leadership. I suspect, with no direct evidence, that the surprising sluggishness in sales and refinancing is not due to the market, so much as it is with a pending buyout. GLTA

Well that certainly would be a fortunate outcome but the current valuation is not reflective of it. The 510k clearance and CLIA-waiver with the FDA must definitely impact near terms sales as many clients might be waiting for these to sign in. Either way the key will be versioning for them.

<< Previous

Bullboard Posts

Next >>

HPQ Silicon updates shareholders on Fumed Silica Reactor developments